Company intelligence / Profile preview

Jones Pharmaceuticals

St. Louis, Missouri, USA

Ownership: Private
Development stage: Other

Overview

Jones Pharmaceuticals, formerly known as Jones Medical Industries, was a specialty pharmaceutical company focused on the development and commercialization of branded prescription products. The company established a strong market presence in the endocrinology sector, particularly in thyroid health, with its flagship product Levoxyl. Jones Pharmaceuticals also marketed treatments for other conditions, including infectious diseases and critical care. In 2000, the company was acquired by King Pharmaceuticals for approximately $3.4 billion, which was subsequently acquired by Pfizer in 2011.

Therapeutic areas: EndocrinologyOtherInfectious Diseases
Modalities: Small moleculeHormoneRadiopharmaceutical
Industry: Biotech

Beyond the preview

Go deeper on Jones Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jones Pharmaceuticals.

Explore the full profile